CRISPR-Cas9 GENE EDITING: MECHANISMS, CLINICAL APPLICATIONS, AND FUTURE PERSPECTIVES
Open Access
- 4 April 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Abstract
The system of gene editing known as the CRISPR-Cas9 system has revolutionized the field of gene editing and provides a platform that allows for the modification of genetic sequences with precision and efficiency, having implications for both the basic research of science and for treatments. Its mechanism, which is derived from bacterial adaptive immunity, consists of a guide RNA that leads to specific epigenetic DNA sites a nuclease named Cas, to target it for cleavage; this permits gene correction, inactivation, or insertion. The clinical potential of this technology is enormous with applications ranging from hereditary diseases, oncology, and infectious diseases. Of note too, the approvals from the FDA for therapies targeted at the treatment of sickle cell anemia and beta thalassemia speaks volumes to its transformative effect on what was previously in-treatable conditions. In oncology, the technologies are increasing immunotherapies by engineering T-cells and interfering with immune checkpoints, but also working on viral genomes (e.g. HIV, HBV) and destroying antibiotic-resistance genes in bacteria. However, there are still major challenges such as off-target effects, in vivo delivery efficiency and possible immunogenicity of Cas proteins. Future advancements are dedicated to refine the use of the CRP systems using advanced variants such as base and prime editors, and to extend the toolkit by Cas12 and Cas13 for RNA/DNA targeting, as well as devising innovative delivery systems for overcoming the biological barriers. Ethical, regulatory, and societal considerations are paramount in the continued promotion and progressive growth of this technology.Keywords
This publication has 117 references indexed in Scilit:
- Advancing Precision Medicine: Recent Innovations in Gene Editing TechnologiesAdvanced Science, 2025
- Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosisClinical and Experimental Medicine, 2025
- Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome EditingSmall Science, 2024
- Viral and nonviral nanocarriers for in vivo CRISPR-based gene editingNano Research, 2024
- An Update on the Application of CRISPR Technology in Clinical PracticeMolecular Biotechnology, 2023
- CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biologyMolecular Biology Reports, 2022
- CRISPR/Cas technology as a promising weapon to combat viral infectionsBioEssays, 2021
- DGK and DZHK position paper on genome editing: basic science applications and future perspectiveBasic Research in Cardiology, 2021
- A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous SystemJournal of Neuroimmune Pharmacology, 2019
- Gene Editing in der Krebsforschung: technische, ethische und rechtliche AspekteDer Onkologe, 2019